The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market. The market is huge — a potential $150 billion a year by the end of the decade — and any financial miss, or negative data of any kind, will trigger outsized sell-offs. This…
The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned against using it for cosmetic purposes without a doctor’s prescription. US drug giant Eli Lilly announced last month that Mounjaro, for treating obesity and type 2 diabetes, had been approved by the Department of…
The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned against using it for cosmetic purposes without a doctor’s prescription. US drug giant Eli Lilly announced last month that Mounjaro, for treating obesity and type 2 diabetes, had been approved by the Department of…
Google reported strong earnings after the close Tuesday. (Photo by Alexander Koerner/Getty Images) Getty Images Key Takeaways Tech Earnings And Economic Data Bring Mixed Signals For Market Direction Alphabet’s Strong Cloud Growth Boosts Sector; AMD Dips On Guidance Optimism Grows Despite Mixed Earnings And Slight Economic Slowdown Signs It’s been a quiet start to the…
In This Story This week promises to be exceptionally busy, with a blend of financial updates and festive celebrations. Investors are bracing for a flurry of major earnings reports, providing a crucial snapshot of how various sectors are navigating the current economic landscape. McDonald’s is facing its first lawsuit from the Quarter Pounder E. coli…
The UK government has announced a novel initiative trial to offer weight loss medication Mounjaro to people with obesity who are unemployed, to improve their health and help them re-enter the workforce, said British Health Minister Wes Streeting said on Tuesday. The trial is part of a broader NHS strategy that offers weight-loss medication to…